78 related articles for article (PubMed ID: 12396831)
1. Universal tumor antigens as targets for immunotherapy.
Gordan JD; Vonderheide RH
Cytotherapy; 2002; 4(4):317-27. PubMed ID: 12396831
[TBL] [Abstract][Full Text] [Related]
2. Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients.
Maecker B; von Bergwelt-Baildon MS; Anderson KS; Vonderheide RH; Anderson KC; Nadler LM; Schultze JL
Clin Exp Immunol; 2005 Sep; 141(3):558-62. PubMed ID: 16045747
[TBL] [Abstract][Full Text] [Related]
3. Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors.
Liu R; Mitchell DA
Cancer Immunol Immunother; 2010 Feb; 59(2):183-93. PubMed ID: 19756596
[No Abstract] [Full Text] [Related]
4. Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges.
Srivastava PK; Duan F
Cancer Immunol Immunother; 2013 May; 62(5):967-74. PubMed ID: 23604106
[TBL] [Abstract][Full Text] [Related]
5. A listing of human tumor antigens recognized by T cells.
Renkvist N; Castelli C; Robbins PF; Parmiani G
Cancer Immunol Immunother; 2001 Mar; 50(1):3-15. PubMed ID: 11315507
[No Abstract] [Full Text] [Related]
6. Cancer genes and the pathways they control.
Vogelstein B; Kinzler KW
Nat Med; 2004 Aug; 10(8):789-99. PubMed ID: 15286780
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications.
Osborne C; Wilson P; Tripathy D
Oncologist; 2004; 9(4):361-77. PubMed ID: 15266090
[TBL] [Abstract][Full Text] [Related]
8. Does the immune system naturally protect against cancer?
Corthay A
Front Immunol; 2014; 5():197. PubMed ID: 24860567
[TBL] [Abstract][Full Text] [Related]
9. Tumor antigen-specific CD4+ T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategies.
Protti MP; De Monte L; Di Lullo G
Tissue Antigens; 2014 Apr; 83(4):237-46. PubMed ID: 24641502
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunoediting: from immunosurveillance to tumor escape.
Dunn GP; Bruce AT; Ikeda H; Old LJ; Schreiber RD
Nat Immunol; 2002 Nov; 3(11):991-8. PubMed ID: 12407406
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells in cancer immunotherapy.
Nishikawa H; Sakaguchi S
Curr Opin Immunol; 2014 Apr; 27():1-7. PubMed ID: 24413387
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T lymphocytes: a critical component of antitumor immunity.
Ostrand-Rosenberg S
Cancer Invest; 2005; 23(5):413-9. PubMed ID: 16193641
[TBL] [Abstract][Full Text] [Related]
13. The immunobiology of cancer immunosurveillance and immunoediting.
Dunn GP; Old LJ; Schreiber RD
Immunity; 2004 Aug; 21(2):137-48. PubMed ID: 15308095
[TBL] [Abstract][Full Text] [Related]
14. Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues.
de Jonge H; Iamele L; Maggi M; Pessino G; Scotti C
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672007
[TBL] [Abstract][Full Text] [Related]
15. HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma.
Aref AM; Hoa NT; Ge L; Agrawal A; Dacosta-Iyer M; Lambrecht N; Ouyang Y; Cornforth AN; Jadus MR
Onco Targets Ther; 2014; 7():1061-70. PubMed ID: 24966688
[TBL] [Abstract][Full Text] [Related]
16. Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.
Schumacher T; Ruehland C; Schultheiss C; Brinkman M; Roedel F; Reiser CO; Hess J; Reichel C
Int J Biomed Sci; 2007 Sep; 3(3):199-205. PubMed ID: 23675044
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells.
Seliger B; Dressler SP; Massa C; Recktenwald CV; Altenberend F; Bukur J; Marincola FM; Wang E; Stevanovic S; Lichtenfels R
Proteomics; 2011 Jun; 11(12):2528-41. PubMed ID: 21595034
[TBL] [Abstract][Full Text] [Related]
18. T-cell-based therapies for malignancy and infection in childhood.
Ahmed N; Heslop HE; Mackall CL
Pediatr Clin North Am; 2010 Feb; 57(1):83-96. PubMed ID: 20307713
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2K(b)-restricted T cell epitope.
Park JS; Kim HS; Park MY; Kim CH; Chung YJ; Hong YK; Kim TG
Cancer Immunol Immunother; 2010 May; 59(5):747-57. PubMed ID: 19936747
[TBL] [Abstract][Full Text] [Related]
20. Adoptive immunotherapy: good habits instilled at youth have long-term benefits.
Paulos CM; Suhoski MM; Plesa G; Jiang T; Basu S; Golovina TN; Jiang S; Aqui NA; Powell DJ; Levine BL; Carroll RG; Riley JL; June CH
Immunol Res; 2008; 42(1-3):182-96. PubMed ID: 18949448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
